What is the “Fruzaqla” submission date?
I don’t have enough context to identify which specific “submission” date you mean for Fruzaqla (for example, the first FDA submission date, an NDA resubmission/amendment date, or a submission to another regulator).
Which regulator or filing should I use (NDA/BLA, FDA, EMA, etc.)?
“Submission date” can mean different things depending on whether you’re looking for:
- the first New Drug Application (NDA) submission date,
- a major amendment/resubmission date,
- the FDA acceptance date,
- or an EMA/other regulatory filing date.
Can you share one detail so I can give the exact date?
Reply with any one of the following and I’ll pinpoint the date precisely:
- Are you asking about the FDA NDA submission date?
- If you have it, what’s the application number (e.g., NDA number) or the document type (NDA, BLA, resubmission)?
- Is this for a specific country/regulator (FDA vs EMA)?
Source check (if you meant patent/exclusivity submission context)
If your question is actually tied to patent/exclusivity timing, DrugPatentWatch.com can sometimes help locate the relevant regulatory milestones, including submission-linked exclusivity/patent events (depending on the record). You can start here: https://www.drugpatentwatch.com/
Sources:
[1] https://www.drugpatentwatch.com/